A comparison of the incidence of micronuclei in blood and bone marrow in 3 strains of mouse dosed with cyclophosphamide or hexamethylphosphoramide (HMPA)-Reference-Cited by-同舟云学术

A comparison of the incidence of micronuclei in blood and bone marrow in 3 strains of mouse dosed with cyclophosphamide or hexamethylphosphoramide (HMPA)

Published:1983-11 Issue:2 Volume:122 Page:143-147
ISSN:0165-7992
Container-title:Mutation Research Letters
language:en
Short-container-title:Mutation Research Letters

Author:

Styles J.A.,Richardson C.R.,Burlinson B.

Publisher

Elsevier BV

Subject

General Medicine

Reference6 articles.

1. Rapid detection of mutagen induced micronucleated erythrocytes by flow cytometry;Hutter;Histochemistry,1982

2. The micronucleus test as part of a short-term mutagenicity test programme for the prediction of carcinogenicity evaluated by 153 agents tested;Jenssen;Mutation Res.,1980

3. Mutagenic activity of 41 compounds in the in vivo micronucleus assay;Salamone;Progr. Mutation Res.,1981

4. The persistence of micronuclei in peripheral blood erythrocytes: the detection of chromosome breakage in mice;Schlegel;Mutation Res.,1982

5. A rapid screen for cumulative chromosomal damage in mice: accumulation of circulating micronucleated erythrocytes;Schlegel;Mutation Res.,1983

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Micronucleus Test (MNT);Toxic Effects of Mercury;2014

2. The bone marrow micronucleus test and metronidazole genotoxicity in different strains of mice (Mus musculus);Genetics and Molecular Biology;2007

3. The influence of dietary flaxseed and other grains, fruits and vegetables on the frequency of spontaneous chromosomal damage in mice;Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis;2004-07

4. Gamma ray induced bone marrow micronucleated erythrocytes in seven strains of mouse;Mutation Research/Genetic Toxicology and Environmental Mutagenesis;2004-05

5. Murine pharmacogenomics: using the mouse to understand the genetics of drug therapy;Pharmacogenomics;2002-11-01